Explore
← New search
Filters:
North America
✕
Quantum Design (United States)
✕
sorted cd34+ hspcs from primary mpn/saml patients and healthy nbm donors (washu cohort, n=90)
✕
clear all
1 matching publication(s)
RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia.
PMID 39820365 · Nat Commun · 2025
L1
73/100